The FY2025 (Dec) proxy of HCA Healthcare names 24 peer companies for pay. Among HCA Healthcare and these peers, CEO pay was 8th highest of 20 and total shareholder return was 4th highest of 20.
8th highest of 20in HCA Healthcare and its pay peers, FY2025 (Dec) by CEO pay:
$18.8M$79.9M
4th highest of 20in HCA Healthcare and its pay peers, FY2025 (Dec) by total shareholder return:
$65$671
Pay peer group, FY2025 (Dec) proxy
| Thermo Fisher Scientific | ||
| Unitedhealth Group | ||
| Eli Lilly & Co | ||
| Johnson & Johnson | ||
| AbbVie | ||
| Gilead Sciences | ||
| Pfizer | ||
| Amgen | ||
| Abbott Laboratories | ||
| Cigna Group | ||
| Elevance Health | ||
| Bristol Myers Squibb | ||
| Stryker | ||
| CVS HEALTH | ||
| Merck & Co. | ||
| Mckesson | ||
| Centene | ||
| Cardinal Health | ||
| Humana | ||
| Cencora | Not disclosed | Not disclosed |
| Danaher Corporation | Not disclosed | Not disclosed |
| Medtronic | Not disclosed | Not disclosed |
| Molina Healthcare, Inc. | Not disclosed | Not disclosed |
| Tenet Healthcare Corporation | Not disclosed | Not disclosed |
24 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.